as of 12-12-2025 3:56pm EST
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. Through its subsidiaries, the company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
| Founded: | 1970 | Country: | United States |
| Employees: | N/A | City: | CINCINNATI |
| Market Cap: | 6.2B | IPO Year: | N/A |
| Target Price: | $574.25 | AVG Volume (30 days): | 140.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 18.95 | EPS Growth: | -4.21 |
| 52 Week Low/High: | $408.42 - $623.61 | Next Earning Date: | 10-28-2025 |
| Revenue: | $2,530,634,000 | Revenue Growth: | 6.45% |
| Revenue Growth (this year): | 5.91% | Revenue Growth (next year): | 6.21% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
president and CEO
Avg Cost/Share
$437.55
Shares
2,000
Total Value
$875,100.00
Owned After
94,197
SEC Form 4
president and CEO
Avg Cost/Share
$461.28
Shares
3,000
Total Value
$1,383,840.00
Owned After
94,197
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| MCNAMARA KEVIN J | CHE | president and CEO | Nov 24, 2025 | Sell | $437.55 | 2,000 | $875,100.00 | 94,197 | |
| MCNAMARA KEVIN J | CHE | president and CEO | Sep 26, 2025 | Sell | $461.28 | 3,000 | $1,383,840.00 | 94,197 |
See how CHE stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "CHE Chemed Corp - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.